To build scope & capacity for clinical research
New evidence based knowledge
Research into effective clinical practice
- About Us
- Contact Us
For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information
NCCRED Clinical Research Fellowship Program 2019
In 2019 NCCRED developed a multidisciplinary mentoring and training program. In our inaugural year, 3 Research Fellows were selected from a competitive application process, informed by the fellow's experience, interest and career aspirations. Applications were accepted from clinicians of any multidisciplinary background (e.g. Nursing, Allied Health, Medical), practicing in the Alcohol and Other Drugs sector. The candidates have been partnered with a senior clinician-researcher in collaboration with NCCRED staff.
With an ever-increasing number of novel psychoactive substances (NPS) being detected world-wide, clusters of severely unwell patients are presenting to Emergency Departments. There are serious and significant concerns about morbidity and mortality from amphetamine and an increasing array of NPS. The NCCRED fellowship will allow Dr. Kozman to:
This contribute to a national registry and early warning system, culminating in the Emerging Drugs Network of Australia (EDNA); and the Prompt Response Network. This will allow collaboration between prehospital services and health departments; timely notification of acute events; and inform clinical and public health policy.
Dr Mullen is currently the recruiting for the MASKOT (MethAmphetamine use in young people: Sub-anaesthetic ketamine open-label trial) clinical trial, and has been involved in the protocol design, ethical and clinical governance approval and implementation. He will complete his fellowship under the mentorship of Dr Gillinder Bedi, Head of Substance Use Research at Orygen, and a Senior Research Fellow of University of Melbourne. During this Fellowship he will also act as a principal investigator on an NCCRED funded study using cannabidiol for methamphetamine use and has contributed to the Psychostimulant chapter in the upcoming APA Handbook of Neuropsychology and a paper on the effect of COVID-19 restrictions on substance use in young people.
Psychosocial treatment can be effective for people that use methamphetamine, however rates of engagement are often low and dropout from treatment is common. This research explores ways to increase accessibility of treatment and engagement in this group.